Metronomics chemotherapy: time for computational decision support. - Wikidata - wikimedia - TriplyDB

Metronomics chemotherapy: time for computational decision support.

Metronomics chemotherapy: time for computational decision support.

http://www.wikidata.org/entity/Q38235906

about

Metronomic chemotherapy: an attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance A phase Ia/Ib clinical trial of metronomic chemotherapy based on a mathematical model of oral vinorelbine in metastatic non-small cell lung cancer and malignant pleural mesothelioma: rationale and study protocol.Clinical overview of metronomic chemotherapy in breast cancer.Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development.Mathematical modeling for Phase I cancer trials: A study of metronomic vinorelbine for advanced non-small cell lung cancer (NSCLC) and mesothelioma patients.Current achievements and future perspectives of metronomic chemotherapy.Modeling therapeutic response to radioiodine in metastatic thyroid cancer: a proof-of-concept study for individualized medicine.Pharmacometrics-based decision tools facilitate mHealth implementation.Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patients.Frequency-Domain Response Analysis for Quantitative Systems Pharmacology Models.Precision Medicine with Imprecise Therapy: Computational Modeling for Chemotherapy in Breast Cancer.Optimal dynamic regimens with artificial intelligence: The case of temozolomide.Metronomic Chemotherapy with Vinorelbine Produces Clinical Benefit and Low Toxicity in Frail Elderly Patients Affected by Advanced Non-Small Cell Lung Cancer

P2860

Q27023579-3358AFCE-3413-4DEC-A3E7-E22DC9BFB76E Q35994241-4BE7D24E-E21E-4DCB-BAF5-6ADC9D939539 Q38560651-41F0146C-A436-4738-8A4F-DCE44324298B Q38638654-AFB2DDEF-A94D-44BB-A66A-1FBE724EFCEB Q38774653-31D2A3A8-BD28-40CA-B457-C4D85F320643 Q38788234-873CCA3C-E77D-43E8-B9B9-09F95D001097 Q38847122-A28281A2-C952-40D5-97DE-9D1A3ECC0051 Q38998626-16813856-6579-42F3-9CBD-02EEA62A4201 Q40383583-ADE9C6B8-CBD5-4E1E-9CC0-B994726241A4 Q47295403-9A912228-6798-44B9-8960-7F87D9645A2A Q52576799-C283CFFD-024E-4CBA-A880-BA0964F9F39B Q55450692-2631C91E-ACBD-4AA4-BB75-0D7917ED3D60 Q58700430-81131B55-1AF6-4F3C-8C9B-B02654BE6198

P2860

Metronomics chemotherapy: time for computational decision support.

http://www.wikidata.org/entity/Q38235906

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Metronomics chemotherapy: time for computational decision support.

@en

type

label

Metronomics chemotherapy: time for computational decision support.

@en

prefLabel

Metronomics chemotherapy: time for computational decision support.

@en

P1433

Q38235906-70043CDB-F6A2-4B73-8366-3FD49F178692

P1476

Q38235906-C7077391-CCF7-4AD3-8533-FC7B9F7EA791

P2093

Q38235906-2C71269C-6467-4BB0-92F5-6BF39D510FED

Q38235906-39E388E6-23F0-425E-ACA4-E842694203ED

Q38235906-41329EFF-761C-4442-A9C8-7707C0DC1A8D

Q38235906-475DEE97-B417-44EF-AA02-68914E29F189

Q38235906-51B45F2E-61C6-41D2-A209-8DB64D3D79C8

Q38235906-5849802B-5E56-4BAA-8760-8FC5E902A50B

Q38235906-662B6A4F-67A7-4683-B571-E0D077F0B129

Q38235906-AEC9F106-B587-468C-96B7-9C6677CD6BDC

P2860

Q38235906-0093F5F4-56C9-4221-8AF3-9790C786A51A

Q38235906-01745B0A-7B9E-48C0-AA96-EB3240E02F40

Q38235906-03026519-0C77-4818-B5F6-3460001F3B94

Q38235906-0EE37FFA-47A6-4005-BFFA-7859F9B86CDB

Q38235906-1CAFD125-C2FD-4C18-8EA7-E6CDA6E6A899

Q38235906-1FF07F5E-AB84-4F56-8431-93B0C0523387

Q38235906-2B29D3F0-38C1-441E-9E16-BA078B82B4D3

Q38235906-2B9150E3-4430-46A4-812F-781C94D80FA4

Q38235906-2E7E72CF-51F6-4469-A3EE-0C3AE3A05356

Q38235906-32C07CFD-D3C1-41CA-8A75-0B82237860E4

P2888

Q38235906-EBC14D8D-DB5B-402C-9BF8-EBE460695ABC

P304

Q38235906-6492E936-72AD-43F1-BF88-84DFB72973F6

P31

Q38235906-B804FA2C-4C25-4D79-9DE6-6A33FEA77622

P356

Q38235906-01A72B21-7EA3-41BD-9276-4936781A0F15

P433

Q38235906-E54AAD89-A983-46F0-A1D4-BFBF56EA65DC

P478

Q38235906-153FC2B3-F9CF-46CC-BDFE-0B3CA94F402E

P577

Q38235906-E6BD2DF7-1AE9-4086-8DE9-4BA2BC57BAF3

P5875

Q38235906-7B2BF138-A112-4746-888E-B95D96C604E3

P6179

Q38235906-31121E1A-45E3-4E62-9E98-0F416C1F2143

P698

Q38235906-84295E80-BB50-4600-8AD6-23686BA11238

P921

Q38235906-19E6F58F-9349-4816-9D35-2184A7622321

P356

S00280-014-2546-1

P1433

Cancer Chemotherapy and Pharmacology

P1476

Metronomics chemotherapy: time for computational decision support.

@en

P2093

Bruno Lacarelle

http://www.w3.org/2001/XMLSchema#string

Christian Faivre

http://www.w3.org/2001/XMLSchema#string

Christophe Meille

http://www.w3.org/2001/XMLSchema#string

Dominique Barbolosi

http://www.w3.org/2001/XMLSchema#string

Fabrice Barlesi

http://www.w3.org/2001/XMLSchema#string

Joseph Ciccolini

http://www.w3.org/2001/XMLSchema#string

Nicolas André

http://www.w3.org/2001/XMLSchema#string

Xavier Elharrar

http://www.w3.org/2001/XMLSchema#string

P2860

Dose individualization of carboplatin after a 120-hour infusion schedule: higher dose intensity but fewer toxicities.

Using pharmacokinetic and pharmacodynamic modeling and simulation to evaluate importance of schedule in topotecan therapy for pediatric neuroblastoma.

Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.

Safety and efficacy of vinorelbine in the treatment of non-small cell lung cancer

Issues regarding improving the impact of antiangiogenic drugs for the treatment of breast cancer

Bayesian clinical trials in action

Oral vinorelbine: role in the management of metastatic breast cancer.

Efficacy and Safety of the All-Oral Schedule of Metronomic Vinorelbine and Capecitabine in Locally Advanced or Metastatic Breast Cancer Patients: The Phase I-II VICTOR-1 Study

Intermittent metronomic drug schedule is essential for activating antitumor innate immunity and tumor xenograft regression.

Metronomic chemotherapy: Back to the future!

P2888

s00280-014-2546-1

P304

647-652

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-014-2546-1

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264432814

http://www.w3.org/2001/XMLSchema#string

P6179

1046680156

http://www.w3.org/2001/XMLSchema#string

P698

25082520

http://www.w3.org/2001/XMLSchema#string

P921